Analysis of Organo Corporation (6368)
Organo Corporation (symbol: 6368) has been showing some interesting price movements and technical indicators in the past few days. Here is a brief analysis based on the provided data:
1. Price Movement:
- The closing prices have been fluctuating between 7890 and 8660 in the last 10 days.
- There seems to be some volatility in the stock, with price highs and lows varying significantly.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) values have been fluctuating around the 50-60 range, indicating moderate momentum in the stock.
- MACD Indicator: The Moving Average Convergence Divergence (MACD) values have shown some divergence, with the MACD histogram fluctuating around 0.
- Moving Averages: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been relatively close to each other, indicating a stable trend.
3. Overall:
- The stock seems to be trading within a range, with some volatility but no clear trend.
- The technical indicators suggest a moderate momentum but no strong signals for a trend reversal or continuation.
Investors may want to monitor the stock closely for any breakout or trend confirmation before making any trading decisions.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has a strong operating cash flow and levered free cash flow. The balance sheet shows a healthy current ratio, but a relatively high total debt to equity ratio. The profit margin and operating margin are both positive, indicating profitability. The company's fiscal year ends in September 2023, with notable figures such as revenue, EBITDA, and net income.
Moving on to stock statistics, key metrics include short ratio, float shares, shares outstanding, and insider and institutional ownership percentages. The company's stock price summary provides information on beta, moving averages, and the range of the stock price over the past year.
Valuations metrics show metrics such as P/E ratios, enterprise value, and market capitalization, providing insights into the company's valuation. Lastly, dividends and splits information includes dividend dates, payout ratios, and dividend yields, as well as details on past stock splits.
Income statement 💸
These are the revenues. Here are the conclusions:
1. The company's sales have been increasing steadily over the past four fiscal years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the net income has also shown a positive trend, rising from $57.4 billion in 2020 to $97 billion in 2023.
3. The EBITDA has also been increasing over the years, indicating that the company's operating performance is improving.
4. The basic and diluted earnings per share (EPS) have remained relatively stable over the years, with slight fluctuations.
5. The company has been able to maintain a healthy gross profit margin, with gross profit increasing along with sales.
6. Operating income has also shown a positive trend, indicating efficient management of operating expenses.
7. The company has been able to generate consistent income from its core operations, as seen in the net income from continuous operations.
8. Overall, the financial performance of the company seems to be on a positive trajectory, with increasing sales and profitability over the years.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided yet. The previous results from February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at a specific time. The results from August 1, 2024, showed an EPS estimate of 1.32.
Balance Sheet
These are balance sheets. Here are the conclusions based on the provided data:
1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,583,000,000.
2. Current assets fluctuate from year to year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $209,017,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $290,437,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
Overall, the company's assets, liabilities, and shareholders' equity have been showing a general upward trend over the years, with some fluctuations in between.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its peak in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational performance and strategic investments.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and years, with an increase compared to the previous year's EPS in most cases. This indicates a favorable outlook for the company's financial performance according to analysts.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods.
Growth estimates
Based on the consensus estimates provided:
- The current year growth rate is 7.5%
- The next quarter growth rate is 4.8%
- The current quarter growth rate is 5.6%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 11%
- The past 5 years compound annual growth rate (CAGR) is 20.15%
It can be observed that the company is expected to experience a significant decrease in growth rate compared to the past 5 years, with a notable drop from 20.15% CAGR to 11% CAGR for the next 5 years. Additionally, there is a slight increase in growth rate from the current year to the next year.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57 USD.MACD of 6368